Adda Nathalie's Form 4 filing
Enanta Pharmaceuticals Inc (ENTA) · filed Mar 3, 2022
- Accession no.
- 0001062993-22-006708
- Filed
- Mar 3, 2022
- Trade date
- Mar 1-2, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.58M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Adda NathalieCIK 0001646976 | Officer (Sr. VP & Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 | Common Stock | MOption exerciseAcquired | +24,339 | $43.46 | +$1,057,772.94 | 59,321 | Direct | |
| Mar 1, 2022 | Common Stock | SSaleDisposed | −24,239 | $70.26 | −$1,703,032.14 | 35,082 | Direct | |
| Mar 1, 2022 | Common Stock | SSaleDisposed | −100 | $71.06 | −$7,106 | 34,982 | Direct | |
| Mar 2, 2022 | Common Stock | MOption exerciseAcquired | +12,481 | $43.46 | +$542,424.26 | 47,463 | Direct | |
| Mar 2, 2022 | Common Stock | SSaleDisposed | −12,481 | $70.07 | −$874,543.67 | 34,982 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 | Common Stock | MOption exerciseDisposed | −24,339 | $0.00 | $0 | 12,481 | Direct | |
| Mar 2, 2022 | Common Stock | MOption exerciseDisposed | −12,481 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.